Androgen and estrogen biosynthesis in mammals requires the 17,20-lyase activity of cytochrome P450 17A1 (steroid 17-hydroxylase/17,20-lyase, CYP17A1). Maximal 17,20-lyase activity in vitro requires the presence of cytochrome b₅ (b5), and rare cases of b5 deficiency in human beings cause isolated 17,20-lyase deficiency. To study the consequences of conditional b5 removal from testicular Leydig cells in an animal model, we generated Cyb5flox/flox:Sf1-Cre (LeyKO) mice. The LeyKO male mice had normal body weights, testis and sex organ weights, and fertility compared to littermates. Basal serum and urine steroid profiles of LeyKO males were not significantly different than littermates. In contrast, marked 17-hydroxyprogesterone (17OHP) accumulation (100-fold basal) and reduced testosterone synthesis (27% of littermates) were observed following hCG stimulation in LeyKO animals. Testis homogenates from LeyKO mice showed reduced 17,20-lyase activity and a 3-fold increased 17-hydroxylase/17,20-lyase activity ratio, which were restored to normal upon addition of recombinant b5. We conclude that Leydig cell b5 is required for maximal androgen synthesis and to prevent 17OHP accumulation in the mouse testis; however, the b5-independent 17,20-lyase activity of mouse P450 17A1 is sufficient for normal male genital development and fertility. LeyKO male mice are a good model for the biochemistry but not the physiology of isolated 17,20-lyase deficiency in human beings. On behalf of my coauthors, I submit this revised manuscript entitled, "Impaired 17,20-lyase activity in male mice lacking cytochrome b5 in Leydig cells," to Molecular Endocrinology. We appreciate the careful reviews, and we have addressed all of the referees' comments as detailed in the enclosed files.
4. Why do the cortisol levels in the WT animals (basal) exceed those of the TesKO mice by 30-fold; and why are these levels non-detectable after hCG stimulation? (Table 1 and  Table 2 ). **In mouse plasma, corticosterone concentrations exceed those of cortisol by up to 3 orders of magnitude. The plasma cortisol concentrations are quite low in all animals with high variability both before and after hCG stimulation. Consequently, none of these cortisol differences are statistically or physiologically significant. To avoid confusion, we have deleted cortisol and cortisone data from Table 1 Minor Figure 1B , the western blot for the CYB5 knockdown should be repeated since it is not publication quality **We repeated the b5 immunoblots, which are notoriously difficult, using a variety of modifications to arrive at the best conditions (page 6). We now have reproducible data with good quality blots using both liver and testis homogenates from LeyKO and WT animals, which are shown in Figure 1B . We could not demonstrate a difference in b5 immunoreactivity in either liver or testis using whole tissue homogenates. This result is not surprising, as the Leydig cells comprise only ~5% of the testis mass. We also found a second major protein species in testis homogenates from all animals, which might be related to the difference in sample preparation for testis versus liver proteins. This result and analysis are discussed in the text, page 8. The entire b5 blot is shown below:
The mice are referred to as either TesKO or LeyKO only one name should be used. **We regret this error in the version of the abstract entered via the portal. LeyKO has been now used consistently and exclusively.
Reviewer #2: In the manuscript entitled 'Impaired 17,20-lyase activity in male mice lacking cytochrome b5 in Leydig cells' by Sondhi and colleagues describe studies aimed at assessing the effect of targeted disruption of cytochrome b5 on steroidogenic capacity. The authors employ a tissue-specific mouse model where the expression of cytochrome b5 is deleted in testis to define the role of this cofactor in Leydig cell androgen synthesis. Comprehensive metabolomics profiling of steroid metabolites in plasma and urine were performed. In contrast to the phenotype of humans recently reported where mutations in CYB55A confer 17,20-lyase deficiency, deletion of the gene in mice has no effect on fertility. The authors provide data to support the conclusion that the 17,20-lyase activity in mouse exhibits cytochrome b5-independent components that are sufficient to confer normal reproductive development and fertility. Overall this is a brief, but well-written study that describes the importance of developing appropriate models to investigate human disease states. There are no major concerns. However, the authors may want to consider the following: 1.
The quality of the cytochrome b5 western blot should be improved **See comment above regarding new immunoblots shown in Figure 1B .
2.
What would be the effect of incubating testicular homogenates to recombinant cytochrome b5 where mutations found by Idowiak et al., are introduced. **The reviewer is inquiring whether inactive forms of b5 can influence P450 17A1 activity. This is an interesting question, and our laboratory has conducted extensive experiments to identify the key residues on b5 that are responsible for stimulation of 17, 20-lyase activity. We have published these results in references 27, 28, and related papers such as Peng & Auchus Biochemistry 2013;52:210-220.
Abstract 27
Androgen and estrogen biosynthesis in mammals requires the 17,20-lyase activity of cytochrome P450 28 17A1 (steroid 17-hydroxylase/17,20-lyase, CYP17A1). Maximal 17,20-lyase activity in vitro requires the 29 presence of cytochrome b5 (b5), and rare cases of b5 deficiency in human beings causes isolated 17,20-30 lyase deficiency. To study the consequences of conditional b5 removal from testicular Leydig cells in an 31
animal model, we generated Cyb5 flox/flox :Sf1-Cre (LeyKO) mice. The LeyKO male mice had normal body 32 weights, testis and sex organ weights, and fertility compared to littermates. Basal serum and urine steroid 33 profiles of LeyKO males were not significantly different than littermates. In contrast, marked 17-34 hydroxyprogesterone (17OHP) accumulation (100-fold basal) and reduced testosterone synthesis (27% of 35 littermates) were observed following hCG stimulation in LeyKO animals. Testis homogenates from 36 LeyKO mice showed reduced 17,20-lyase activity and a 3-fold increased 17-hydroxylase/17,20-lyase 37 activity ratio, which were restored to normal upon addition of recombinant b5. We conclude that Leydig 38 cell b5 is required for maximal androgen synthesis and to prevent 17OHP accumulation in the mouse 39 yielding 17-hydroxypregnenolone and 17-hydroxyprogesterone (17OHP), respectively. The 17,20-lyase 48 reaction, however, shows species-specific substrate preferences, with human P450 17A1 catalyzing the 49 conversion of 17-hydroxypregnenolone to dehydroepiandrosterone about 50-fold more efficiently than 50 17OHP to androstenedione (AD), whereas the rodent enzymes utilize both pathways. The 17,20-lyase 51 reaction is more vulnerable than the 17-hydroxylase reaction to disruption from the abundance of its 52 electron transfer protein cytochrome P450-oxidoreductase (POR) (1) , to mutations in POR, and to 53 phospholipid composition. Because the 17,20-lyase activity is the sole gateway to all androgens, the 54 potent P450 17A1 inhibitor abiraterone was developed for the treatment of castration-resistant prostate 55 cancer (2,3). The prodrug abiraterone acetate suppresses testosterone (T) synthesis in prostate cancer 56 patients and normalizes androgen production in adult women with uncontrolled classic 21-hydroxylase 57 deficiency (4). 58
Cytochrome b5 (b5) is a small, highly conserved 15-kDa hemoprotein cofactor for multiple 59 oxidative reactions, including the metabolism of fats and steroids, reduction of methemoglobin to 60 hemoglobin, and the catabolism of xenobiotics and drugs (5-9). The full-length microsomal form of b5 is 61 found on the cytoplasmic side of the endoplasmic reticulum in many tissues, and a soluble form lacking 62 the C-terminal membrane anchor is abundant in erythrocytes (10). Multiple studies since the 1960s have 63 confirmed the importance of b5 as a modifier of various cytochrome P450 activities, although its 64 mechanism of action remains controversial and might vary with P450 isoforms and substrates. Several 65 mechanisms have been proposed, including direct transfer of electrons to P450s from either NADH-66 cytochrome b5 reductase or POR (11) versus an allosteric effect on the P450s and/or POR (12,13). 67
Depending on the substrate and enzyme, b5 can serve as an obligate component of the reaction or as a 68 modifier of a reaction for the same P450. For example, P450 2B4-catalyzed metabolism of 69 methoxyflurane shows an absolute requirement for b5 (14); in contrast, b5 inhibits the metabolism of 70 benzphetamine by P450 2B4 (15). In the P450 4A subfamily, which consists of eicosanoid and fatty acid 71 hydroxylases, b5 can increase or decrease the Km of the reaction, depending on the substrate involved 72 (16). 73 P450 17A1 also shows substrate-specific modulation via b5 (12). Similar to the substrate-specific 74 modulation of activity observed with b5 and other P450s, b5 stimulates the 17, 20-lyase reaction rate >10-75 fold when 17-hydroxypregnenolone or 17OHP are substrates, but b5 only increases the conversion of 5-76 pregna-3,17-diol-20-one to androsterone-the most efficient 17,20-lyase reaction for human P450 77 17A1-by 3-fold (17, 18 temperature-controlled environment with a 6 AM -6 PM light/dark cycle. Unless specified, mice used in 117 experiments were 6-8 weeks old. 118
Fertility was assayed by placing fertile wild-type (WT) female mice with individually housed 119 male mice. Breeding cages were surveyed daily for the presence of pups that if found were removed and 120 sacrificed. Adult animals were sacrificed by asphyxiation with isoflurane and, then exsanguination via 121 cardiac puncture; pups were sacrificed by decapitation. For stimulation of steroidogenesis, hCG (Sigma) 122 was dissolved in a 0.9% saline solution for a final concentration of 100 mIU/mL. Mice were administered 123 100 L of hCG solution or vehicle via an intraperitoneal injection and sacrificed 2 hours later. Tissue 124 fixation, hematoxylin and eosin staining, and microscopy for histological analyses were conducted 125 according to standard protocols. 126
RT-PCR, immunoblotting, urine and blood collection, and dynamic testing 127
For RNA extraction, frozen liver or testis samples were homogenized in 500 L of RNA-128 STAT60 (Isotex Diagnostics), 100 L of chloroform was added, and the phases were separated by 129 centrifugation. The upper phase was removed, and RNA was precipitated with 500 L of ice-cold n-130
propanol. Following centrifugation, the pellet was washed with 70% ethanol, followed by DNase 131 treatment and reverse transcription using random hexamers to generate cDNAs. RT-qPCR analyses used 132 25 ng of cDNA and 150 nmol of primers mixed with SYBR GreenER PCR Master Mix (Invitrogen). 133
Reactions were performed on an ABI PRISM 7900 HT (Applied Biosystems), and mRNA levels were 134 calculated by normalization to cyclophilin using the comparative Ct method. Cyb5 primers were designed 135 using Primer Express (Applied Biosystems): 5'-CGATCTGACCAAGTTTCTCGAA-3', 5'-136
CCCCAGCTTGCTCTCTTAGG-3' 137
For protein analyses, frozen livers were homogenized in protein-lysis buffer containing 10 mM 138
TrisHCl (pH 7.5), 150 mM NaCl, 0.5% NP40, 10% glycerol, 5 mM EDTA and 1 complete mini protease 139 inhibitor tablet per 10 mL (Roche 11836153001). Samples were homogenized and centrifuged at 13,000 140 xg for 20 minutes. The supernatant was assayed for protein concentration using a colorimetric assay. 141
Testis homogenates used for enzyme assay (see below) were mixed 2:1 with sample buffer (Laemmli 142 sample buffer, Bio-Rad) and boiled for 5 min. For immunoblots, 40-50 g of protein was resolved on 4-143 20% Tris-glycine SDS-PAGE gels and transferred to polyvinylidene difluoride membranes at 7 V for 1 144 hour. Incubation with primary rabbit polyclonal human anti-Cyb5 antibody (Abcam, 1:500) was 145 performed in Tris-buffered saline containing 0.05% Tween and 3% BSA. After washing, incubation with 146 secondary goat anti-rabbit IgG HRP-conjugated antibody (PerkinElmer, 1:10,000) was performed in Tris-147 buffered saline containing 0.1% Tween and 5% fat-free milk. Clarity Western ECL substrate (Bio-Rad) 148 was used to visualize results. HRP conjugated anti--actin antibody was used as a loading control (Cell 149 Signaling, 1:1,000). 150
Blood obtained through cardiac puncture as previously described was collected in EDTA coated 151 microfuge tubes. Plasma was separated and used for steroid profiling. Urine was collected from the wells 152 of 96-well plates placed at the base of cages with individual mice. Mice were placed in the urine-153 collection cages for 2 hours a day for five days to minimize stress, and urine collected from the same 154 mouse on different days was pooled for analysis. 155
Enzyme assay 156
Recombinant tetrahistidine-tagged human b5 was prepared as described (27). Testes (80-130 mg) 157
were homogenized in 0.25 mL of 0.25 M sucrose containing 10 mM TrisHCl pH 7.0 and 1 mM EDTA 158 with 10 strokes of Teflon homogenizer. The debris was pelleted by centrifuging 3 min at 5,000 xg and 159 discarded, and the decanted crude homogenate was stored frozen at -20C until use. Aliquots (10 μL) 160
were incubated with 10 μM [
3 H]-labeled progesterone or 17-hydroxyprogesterone (100,000 CPM per 161 incubation) and 1 mM NADPH in 50 mM potassium phosphate buffer pH 7.4 with and without 2-30 pmol 162 b5 (estimated 5 pmol b5/pmol P450 17A1 based on activity) at 37C in a total volume of 0.5 mL for 30 163 min. Steroids were extracted with 1 mL 1:1 ethyl acetate/isooctane or 1 mL dichloromethane. After 164 centrifugation at 8000 rpm for 1 min, the organic phase was transferred into glass tubes and concentrated 165 under nitrogen. Samples were reconstituted with 20 µL methanol, and 5 µL samples were injected into an 166 Agilent 1260 Infinity HPLC system equipped with UV detector and β-RAM4 in-line scintillation counter 167 (LabLogic, FL, USA). Steroid standards and samples were resolved on a Kinetex 50 x 2.1 mm, 2.6 m 168 particle size C8 column (Phenomenex) and methanol-water gradients as described (28), mixed with Bio-169 SafeII scintillation cocktail (Research Products International), and quantitated by integration of 170 radioactivity peaks using Laura4 software (LabLogic). 171
Plasma steroid profiling by liquid chromatography-tandem mass spectrometry (LC-MS/MS) 172
A 50 µL aliquot of plasma was deproteinated with acetonitrile and methanol containing 173 deuterated internal standards, and steroids were extracted and quantitated using an Agilent 1290 binary 174 pump HPLC attached to an Agilent 6490 triple quadrupole tandem mass spectrometer as described 175 (29,30). Assay performance characteristics and precursor/product ion pairs were reported in these 176
references. 177

Urine steroid metabolite profiling by gas chromatography-mass spectrometry (GC-MS) 178
Steroids in a 0.5-1 mL sample of urine were extracted, derivatized, and quantitated as previously 179 described (31). In mice, the major androgen metabolite is an incompletely characterized 180 androstanetriolone, which when fully silylated gives a molecular ion of M + = 416 m/z. Excretion of 181 metabolites in untimed samples were normalized to creatinine and expressed as g/mg creatinine. 182
Results 183
Generation of Leydig cell b5 knockout mice (LeyKO) 184
To study the in-vivo role of microsomal b5 in testicular steroid synthesis, we generated Ledyig-185 (Table 1) . No significant differences were observed between the two groups. Additionally, no differences 199 in body weight were observed between LeyKO and floxed littermates ( 
LeyKO mice show slight changes in basal plasma and urine steroid profiles 209
Given the strong stimulatory effect of b5 on the P450 17A1-catalyzed 17,20-lyase reaction, we 210 anticipated that deletion of b5 from Leydig cells would decrease circulating 19-carbon steroids AD and T 211 and lead to an accumulation of 21-carbon precursors, particularly 17OHP. Using LC-MS/MS to profile 212 plasma steroids, we found neither a significant decrease in AD and T nor a significant increase in 17OHP 213
and Prog (Table 1) . Furthermore, plasma 17OHP concentrations were consistently low or undetectable 214 (<0.5 ng/mL) in both LeyKO mice and floxed littermates, and in agreement with prior studies, plasma T 215 did not exceed 0.5-1 ng/mL (32). These results suggest that residual 17,20-lyase activity in the absence of 216 b5 was sufficient to maintain the low basal level of T synthesis in male mice without accumulation of 217
precursors. An alternative explanation is that b5-dependent extra-testicular androgen synthesis 218 compensates for the lack of testicular AD and T production in LeyKO mice; however, this hypothesis is 219 unlikely given the minor reductions in plasma T found in global b5-null animals (23). To confirm these 220 findings, we performed urinary steroid metabolite profiling by GC/MS, which was used to demonstrate 221 impaired 17,20-lyase activity in patients with b5 deficiency (21). Urine samples from 10-week-old 222 LeyKO mice and floxed littermates (n=10 each group) showed slightly lower amounts of the major 223 androstanetriolone androgen metabolite compared to floxed littermates (AUC/mL urine = 2042000  224 927000 versus 2786000  865000, respectively, p = 0.09). These data demonstrate minimal changes in 225 basal steroid production in LeyKO mice. 226
Stimulation of steroid production exposes accumulation of 17OHP and Prog in LeyKO mice 227
Unlike human beings, exposure of male mice to a receptive female or soiled bedding from a 228 
Addition of b5 to testicular homogenates from LeyKO mice restores deficient 17,20-lyase activity 252
To confirm that loss of b5 is the Leydig cells is responsible for low 17,20-lyase activity in LeyKO 253 animals, we assayed 17-hydroxylase and 17,20-lyase activities in testicular homogenates and expressed 254 the results as the hydroxylase/lyase ratio for each testis sample, to correct for variations in P450 17A1 255 content and homogenate quality. The hydroxylase/lyase ratio increased from 1.7 in wild-type mice to 4.7 256 in LeyKO mice ( Figure 2C ). Addition of exogenous b5 to the testicular homogenates restored a normal 257 hydroxylase/lyase ratio to LeyKO mice homogenates but did not change the ratio for the wild-type 258
homogenates, confirming that lack of Leydig cell b5 was responsible for the observed decrease in 17,20-259 lyase activity. 260
Fertility and hCG stimulation of aged LeyKO mice 261
Healthy mice have no observed decrease in plasma T with aging (36). Given their impaired 262
17,20-lyase activity, we hypothesized that absence of b5 might lead to decreased plasma T and 263 consequently decreased fertility with increasing age in LeyKO mice. To examine this possibility, LeyKO 264 mice and floxed littermates with an average age of 596  25 days were subjected to the same battery of 265 testing as described above for the younger animals. We found no differences in fertility (litter size and 266 frequency, data not shown), body weight, or lean weight and fat content assessed by MRI between the 2 267 cohorts (Table 2 ). Similar to young adults, aged LeyKO mice had hCG-stimulated plasma T 268 concentrations approximately 50% that of floxed littermates with an accumulation of plasma 17OHP 50-269 fold higher than floxed littermates (Table 2) . Similarly, homogenates of aged LeyKO mouse testis had an 270 increased hydroxylase/lyase ratio compared to floxed littermates, which was restored to normal upon 271 addition of exogenous b5 (data not shown). Consequently, we found no significant decline in testicular 272 function or premature failure in aged LeyKO mice. 273
Activation of alternate pathway of steroidogenesis is not responsible for normal male phenotype of 274
LeyKO mice 275
An alternate pathway to dihydrotestosterone (DHT), originally described in the tammar wallaby, 276 is also found in both rodents and human steroidogenic cells (37). The 5-reductase isoform Srd5a1, 277 known to convert T to DHT, also utilizes Prog and 17OHP as substrates to form 5-reduced pregnanes, One limitation to our study is the use of Sf1-Cre transgene for conditional deletion of the Cyb5a 305 gene. Sf1 is also expressed in the adrenal cortex, gonadotropes, and certain regions of the hypothalamus. 306
In mice, P450 17A1 expression in the adrenal cortex is low, as evidenced by the high plasma 307 corticosterone in all animals ( Figure 2 ). While our data hint that other 21-carbon steroids of adrenal origin 308 also accumulate in LeyKO animals after hCG stimulation, the effect is small compared to the massive rise 309 in 17OHP. Thus, the simultaneous loss of b5 in the adrenal cortex is unlikely to confound our 310 conclusions, whereas the preservation of hepatic b5 expression is a unique advantage of our mouse model 311 support our conclusions, although our data might underestimate the true magnitude of the b5 effect. We 321 studied only male animals due to the additional complexities introduced from the estrus cycle and 322 dominant conversion of androgens to estrogens in the ovary of female mice. Nevertheless, subsequent 323 experiments with female "LeyKO" animals, engineered to lack b5 in the theca and granulosa cells, would 324 be a logical topic of future studies. 325
Previous work on b5 physiology has focused on its in vitro modulation of various P450s or its in 326 vivo effects on metabolism of various xenobiotics (22). A global b5-null mouse has been described with 327
substantial defects in hepatic and extra-hepatic drug metabolism (23). The global b5-null mice were born 328 in normal Mendelian ratios, and were unexpectedly found to be fertile with no overt phenotype. Similar to 329 observations with the global b5-null animals, LeyKO mice had normal fertility without gross or 330 histological changes in the testis, epididymis, vas deferens, seminal vesicles or preputial glands. Our data 331 demonstrate that normal androgen physiology is preserved in this strain of male mice whether b5 is 332 deleted from the Leydig cells alone or simultaneous deletion from the liver as well, which is likely to 333 reduce testosterone catabolism. 334
In contrast to these findings in mice, human patients with CYB5A mutations and a 46XY 335 karyotype are born with ambiguous genitalia and are universally infertile (21,39). The 17,20-lyase activity 336 of microsomes isolated from LeyKO mice is significantly reduced and comparable to the decrease in 337 17,20-lyase activity noted in transfected HEK293 cells expressing human P450 17A1 and b5 mutation 338 H44L (21), demonstrating that b5 is required for maximal 17,20-lyase activity in the Leydig cells of both 339 mice and humans. The differences in sexual development and maturation observed between LeyKO mice 340 and human patients potentially stem from differences in the specific androgen concentrations required for 341 fetal development. Decades of research has revealed that human fetal male sexual development is 342 dependent on the production of T and its subsequent conversion to DHT via SRD5A2 (40). Human 343 amniotic T concentrations, measured between 11 and 21 weeks gestation, average 0.17 ng/mL for male 344 fetuses and 0.1 ng/mL for female fetuses (41). Direct measurements of fetal T from fetal vein sampling 345 between 15 and 38 weeks of gestation average 0.61 ng/mL for male fetuses and 0.22 ng/mL for female 346 fetuses (42). T concentrations below a threshold lead to graded degrees of impaired virilization, which are 347 inversely correlated. Male mouse fetal testes predominately produce T plus 5-androstene-3,17-diol at 348 ± SD, and statistics were determined with two-tailed t-test (*, p < 0.05; **, p < 0.005; ***, p < 0.0005). 525 
